名臣健康
(002919)
| 流通市值：43.59亿 | | | 总市值：43.91亿 |
| 流通股本：2.64亿 | | | 总股本：2.66亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 895,971,000.05 | 417,505,779.32 | 1,514,450,125.51 | 1,078,874,052.86 |
| 营业收入 | 895,971,000.05 | 417,505,779.32 | 1,514,450,125.51 | 1,078,874,052.86 |
| 二、营业总成本 | 909,901,188.34 | 414,286,951.77 | 1,495,723,182.31 | 1,031,137,681.82 |
| 营业成本 | 379,916,641.35 | 169,292,297.96 | 694,807,506.16 | 503,196,868.03 |
| 税金及附加 | 2,266,980.78 | 1,005,928 | 4,906,861.94 | 3,271,680.57 |
| 销售费用 | 436,434,620.94 | 204,223,994.86 | 641,220,529.8 | 417,668,460.24 |
| 管理费用 | 56,530,413.5 | 23,549,959.2 | 95,710,838.83 | 66,119,377.78 |
| 研发费用 | 32,290,652.94 | 15,078,392.37 | 57,625,371.08 | 40,483,039.47 |
| 财务费用 | 2,461,878.83 | 1,136,379.38 | 1,452,074.5 | 398,255.73 |
| 其中:利息费用 | 1,803,851.74 | 882,983.77 | 1,804,851.98 | 873,631.07 |
| 其中:利息收入 | 179,419.92 | 105,777.16 | 655,223.43 | 518,854.47 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 421,707.67 | 179,616.36 | 102,684,755 | 460,242.24 |
| 加:投资收益 | 290,915.25 | 96,350.56 | 342,486.32 | 217,482.72 |
| 资产处置收益 | 16,027.21 | 33,123.39 | -510,953.34 | 237,163.74 |
| 资产减值损失(新) | -2,714,016.18 | - | -32,631,301.64 | -2,863,121.62 |
| 信用减值损失(新) | 6,445,151.19 | 1,109,186.3 | -35,652,866.81 | -8,617,104.41 |
| 其他收益 | 159,478.75 | 143,185.21 | 1,782,834.55 | 1,386,702.34 |
| 四、营业利润 | -9,310,924.4 | 4,780,289.37 | 54,741,897.28 | 38,557,736.05 |
| 加:营业外收入 | 210,325.67 | 28.33 | 42,572.51 | 45,195.72 |
| 减:营业外支出 | 345,259.58 | 335,106.02 | 1,154,423.84 | 738,235.08 |
| 五、利润总额 | -9,445,858.31 | 4,445,211.68 | 53,630,045.95 | 37,864,696.69 |
| 减:所得税费用 | -1,927,317.75 | -3,809,836.85 | 25,828,796.83 | -4,538,555.32 |
| 六、净利润 | -7,518,540.56 | 8,255,048.53 | 27,801,249.12 | 42,403,252.01 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -7,518,540.56 | 8,255,048.53 | 27,801,249.12 | 42,403,252.01 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -5,067,938.73 | 9,171,805.41 | 28,308,089.87 | 42,549,813.95 |
| 少数股东损益 | -2,450,601.83 | -916,756.88 | -506,840.75 | -146,561.94 |
| 扣除非经常损益后的净利润 | -5,561,967.61 | 9,153,195.01 | -74,745,563.54 | 41,217,097.26 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.02 | 0.03 | 0.11 | 0.16 |
| (二)稀释每股收益 | -0.02 | 0.03 | 0.11 | 0.16 |
| 九、综合收益总额 | -7,518,540.56 | 8,255,048.53 | 27,801,249.12 | 42,403,252.01 |
| 归属于母公司股东的综合收益总额 | -5,067,938.73 | 9,171,805.41 | 28,308,089.87 | 42,549,813.95 |
| 归属于少数股东的综合收益总额 | -2,450,601.83 | -916,756.88 | -506,840.75 | -146,561.94 |
| 公告日期 | 2026-08-26 | 2026-04-28 | 2026-04-28 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |